IDH1 and central nervous system cancer: Patients with higher-grade tumours or/and IDH-WT gliomas exhibit worse NCF than patients with lower-grade or IDH-Mut tumours; those with IDH1-WT gliomas perform worse than those with IDH-Mut gliomas on learning, memory, processing speed, language, executive function, and dexterity tests [24].